Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | ALB | P02768 | 2/20 | 0.37 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.37 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.37 |
| ▸ | CDC25B | P30305 | 1/20 | 0.37 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | PLK1 | P53350 | 3/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6833975 | 0.93 | MAPK1 (0.42) | MAPTMAPK1TDP1NR1H4ALB | |
| SCHEMBL6834031 | 0.87 | MAPT (0.43) | MAPTMAPK1TDP1NR1H4ALDH1A1 | |
| SCHEMBL6835693 | 0.85 | POLB (0.47) | ALDH1A1ALBPTPN2PTPN1PTPN6 | |
| SCHEMBL6833233 | 0.85 | MAPT (0.42) | MAPTMAPK1TDP1NR1H4ALDH1A1 | |
| SCHEMBL6833331 | 0.85 | PTPN2 (0.44) | PTPN2PTPN1PTPN6CDC25BPTPN11 | |
| SCHEMBL6833287 | 0.84 | PLK1 (0.55) | MAPTNR1H4MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL6834575 | 0.84 | PTPN2 (0.46) | PTPN2PTPN1PTPN6CDC25BPTPN11 | |
| SCHEMBL6834131 | 0.84 | PTPN2 (0.46) | PTPN2PTPN1PTPN6CDC25BPTPN11 | |
| SCHEMBL6833910 | 0.84 | KDM4E (0.45) | MAPTMAPK1TDP1NR1H4ALDH1A1 | |
| SCHEMBL6830151 | 0.83 | ALB (0.42) | MAPTMAPK1TDP1NR1H4KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040110802-A1 | Antibacterial benzoic acid derivatives | PHARMACIA & UPJOHN COMPANY | 2004-06-10 | — | — | US | claimed |
| US-20040110802-A1 | Antibacterial benzoic acid derivatives | PHARMACIA & UPJOHN COMPANY | 2004-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040110802-A1 | Antibacterial benzoic acid derivatives | GABRD, GABBR1, GABRA1 | L3MBTL1 2096/4885MAPT 4759/4885MAPK1 2575/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.